Bristol-Myers Squibb was formed in 1989 with the merger of Bristol-Myers and Squibb Corporation.
Bristol-Myers was founded in 1887 by William McLaren Bristol and and John Ripley Meyers in Clinton, New York.
Squibb Corporation was founded by Edward Robinson Squibb in Brooklyn, New York in 1858.
Bristol-Myers Squibb is a pharmaceutical company that develops, licenses, manufacturers, markets, distributes, and sells biopharmaceutical products worldwide.
The company concentrates on cardiovascular care, immunology, metabolics, neuroscience, oncology, and virology.
Bristol-Myers Squibb is dedicated to the research and development of new drugs, and is in phase III clinical trials for various new treatments for HIV, different types of cancer, and Hepatitis C.
Bristol-Myers Squibb markets its products to health care practitioners, hospitals, and managed-care providers in 100 countries.
The company is a member trades publicly on the New York Stock Exchange under the symbol BMY, is #158 on the Fortune 500, is a member of the S&P 500, has 28,000 employees, and had $16.38 billion in revenue in 2013.
Bristol-Myers SquibbBristol-Myers Squibb was formed in 1989 with the merger of Bristol-Myers and Squibb Corporation.
Bristol-Myers was founded in 1887 by William McLaren Bristol and and John Ripley Meyers in Clinton, New York.
Squibb Corporation was founded by Edward Robinson Squibb in Brooklyn, New York in 1858.
History
Bristol-Myers Squibb is a pharmaceutical company that develops, licenses, manufacturers, markets, distributes, and sells biopharmaceutical products worldwide.
The company concentrates on cardiovascular care, immunology, metabolics, neuroscience, oncology, and virology.
Bristol-Myers Squibb is dedicated to the research and development of new drugs, and is in phase III clinical trials for various new treatments for HIV, different types of cancer, and Hepatitis C.
Bristol-Myers Squibb markets its products to health care practitioners, hospitals, and managed-care providers in 100 countries.
The company is a member trades publicly on the New York Stock Exchange under the symbol BMY, is #158 on the Fortune 500, is a member of the S&P 500, has 28,000 employees, and had $16.38 billion in revenue in 2013.
Marissa S.Munar says
Does your Human Resource Manager named was Tim Collins.
Thank you.
CAROL B says
Dear Mr L.. Andreotti, I am writing to for your help PLEASE!… Your company has come out with a wonder drug called. Eliquis. This was such a blessing to be I felt because I am 80 years old and was told I have Mesothelioma (lung cancer–lining of the lung) I was on warfarin 5 mg….well being on Chem….it doesn’t work right because the doses are hard to figure . My Heart Doctor M. Mumma highly recommended Eliquis and gave me samples of it and he was right…So he ordered them thru Walmarts and when they called me and told me how much $660.00 for 3 mos. I don’t have this kind of money being on S.S. So I tried for your Assistance program….which you have to have 105.85 with plan D. I don’t use that….I take very little pills….If I go with a higher plan with my Humana Ins. I can’t afford it….I only make $1200 a month, My condo was built in 1978, and I have a 2001 Chrysler car……I have insurance, and bills I have to be and I get meals on wheels so I can have a nice dinner…. Is there any way in your heart you can help me…..PLEASE/
Matthew Hersh says
I began the application process for assistance programs for Eliiquis on December,3 2018. Since that date I have spoken to many representatives all requesting documents that I have faxed numerous times. I received numerous calls requesting the same documents that have already been faxed and received. I am appalled by the unprofessional and untrained personnel that serve this company. All through this horrible journey I was told that they we’re missing documents and when I told them I faxed them more than once they finally noticed that they were in my file. Today was the last straw when I was denied after all this time because I did not meet the 3 percent of my income for out of pocket to be approved. Nowhere on the application does it say if you do not meet this requirement I will be denied.
I feel as others do that many of your employees need retraining or replacement.
I have dealt with your competition and they never treated me like this. Maybe I should consider changing back to Xarelto….
William Trost says
RE: Patient Assistance Foundation
I realize this is not a profit center for your company, however, if you are unable to treat us with some degree of respect and caring you should discontinue the program. In the past months I have spent in excess of 30 hours on hold before getting to a person who asked for yet another doXXXXent, all of which I have faxed four times and also mailed via certified mail. The nurse in my doctor’s office has been trying to assist me but she has suffered at least 18 hours on hold, then asked for the same thing she had faxed the previous three days. She refuses to waste any more time with your offices so I guess I’m on my own. I have purchased a lot of your products over the years and feel like at this point you just don’t give a S__T.
Sheila Aldrich says
Take your ad for Opdivio off of television. An oncologist should know about this drug and a patient can talk to their doctor if they have a concern. In the ad the guy rattles off about 20 side effects which are disturbing. Take the money you spend on tv and put it into research. What a waste of time–we just flip the channel when these ads appear. So do my friends who also find cancer drug ads disturbing.